Pricing
  1. US-listed companies
  2. Avid Bioservices, Inc.
  3. Financials
  4. Operating income

Avid Bioservices, Inc. (CDMO)

Market cap
$798.9M
P/E ratio
SummaryFinancials
Period EndOperating income (Million USD)YoY (%)
Apr 30, 2024-19-618.69%
Apr 30, 20234-76.65%
Apr 30, 202215+25.97%
Apr 30, 202112-211.91%
Apr 30, 2020-11+94.59%
Apr 30, 2019-6-72.76%
Apr 30, 2018-21-26.97%
Apr 30, 2017-28-49.86%
Apr 30, 2016-56+11.61%
Apr 30, 2015-50+41.43%
Apr 30, 2014-36+25.94%
Apr 30, 2013-28-32.61%
Apr 30, 2012-42

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat